(Z)-1-(phenylamino)-1-(phenylhydrazono)-2-propanone | 78241-05-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (Z)-1-(phenylamino)-1-(phenylhydrazono)-2-propanone
• 英文别名: 1-(phenylamino)-1-(phenylhydrazono)-2-propanone；N-anilino-2-oxo-N'-phenylpropanimidamide
• CAS: 78241-05-1
• 化学式: C₁₅H₁₅N₃O
• 分子量: 253.304
• InChiKey: WZOWHQDAPHJDPZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  53.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (Z)-1-(phenylamino)-1-(phenylhydrazono)-2-propanone 在 PPA 作用下， 反应 0.17h， 以1.4 g的产率得到3-methyl-2-(phenylazo)indole
  参考文献：
  名称：

  New access to 2-(arylazo)-, 2-(arylhydrazo)-, and 2-aminoindoles, -benzofurans, and -thianaphthenes

  摘要：

  DOI：

  10.1021/jo00241a035
• 作为产物：
  描述：

  2-(phenylazo)-3-phenyl-4,6-dimethylindole 在 palladium on activated charcoal 氢气 、 三乙胺 作用下， 以 乙醇 为溶剂， 25.0 ℃ 、3.55 MPa 条件下， 反应 20.0h， 生成 (Z)-1-(phenylamino)-1-(phenylhydrazono)-2-propanone
  参考文献：
  名称：

  New access to 2-(arylazo)-, 2-(arylhydrazo)-, and 2-aminoindoles, -benzofurans, and -thianaphthenes

  摘要：

  DOI：

  10.1021/jo00241a035

文献信息

• Ruthenium complexes of pyridine oxime and azoimine ligands: Syntheses, crystallography, electrochemical and catalytic properties
  作者：Mousa Al-Noaimi、Firas F. Awwadi、Ayman Hammoudeh、Sally Abu-Hmaid、Raja Bader

  DOI：10.1016/j.ica.2018.08.025

  日期：2018.11

  Abstract Five mononuclear ruthenium complexes of the type trans -[RuCl 2 (Azo)(Py-C(R)N = OH)] ( C1–C5 ) Azo = C 6 H 5 N = NC(COCH 3 ) = NC 6 H 4 X, R = CH 3 , X = H ( C1 ), Br ( C 2 ), CH 3 ( C3 ), F ( C4 ); R = H, X = CH 3 ( C5 )} have been synthesised and characterized by spectroscopic (IR, UV-Vis, and NMR) and electrochemical (cyclic voltammetry) techniques. In addition, C2 complex has been further characterized

  摘要反式-[RuCl 2（Azo）（Py-C（R）N = OH）]（C1-C5）类型的五种单核钌配合物Azo = C 6 H 5 N = NC（COCH 3）= NC 6 H 4 X，R ＝ CH 3，X ＝ H（C1），Br（C 2），CH 3（C3），F（C4）；R ＝ H，X ＝ CH 3（C5）}已经合成并通过光谱学（IR，UV-Vis和NMR）和电化学（循环伏安）技术表征。另外，C 2配合物还通过单晶X射线衍射表征。还测试了配合物（C1-C3）在苯乙酮的液相加氢中的催化活性。乙腈中C2的电子吸收光谱已通过时变密度泛函理论进行了建模。
• S1P3 RECEPTOR ANTAGONIST
  申请人：Ohnuma Shin-ya

  公开号：US20090170895A1

  公开（公告）日：2009-07-02

  The present invention relates to a medicine, and more particularly to novel arylamidrazone derivatives having an antagonistic action against S1P 3 receptors and a medicine containing thereof as an active ingredient. The present invention provides an arylamidrazone derivative represented by the following formula (1) or a pharmaceutically acceptable salt thereof: wherein R 1 represents a C 2 -C 8 alkyl group which may be substituted, a phenyl group which may be substituted, an aromatic heterocyclic group which may be substituted, a C 2 -C 8 alkoxy group which may be substituted, or —NR 4 R 5 (wherein R 4 and R 5 , which are identical or different, each represent a hydrogen atom or a lower alkyl group which may be substituted, or R 4 and R 5 may be joined with the adjacent nitrogen atom to form a nitrogen-containing heterocyclic ring which may be substituted); R 2 and R 3 , which are identical or different, each represent a hydrogen atom, a halogen atom, a halo-lower alkyl group, a lower alkyl group, a lower alkynyl group, a lower alkoxy group, a cyano group, a lower alkanoyl group or a lower alkylsulfonyl group; A represents a benzene ring or a heterocyclic ring; D represents a single bond or methylene; m represents an integer from 1 to 3, and n represents an integer from 1 to 5 (with the proviso that the case where R 1 is an ethoxy group, R 2 is a 2,4-dichloro group, R 3 is a hydrogen atom, A is a benzene ring, and D is methylene; and the case where R 1 is an ethoxy group, R 2 is a 2,4-dichloro group, R 3 is a hydrogen atom, a 2-methyl group, a 4-methyl group, a 4-methoxy group or a 4-ethoxy group, A is a benzene ring, and D is a single bond, are excluded).

  本发明涉及一种药物，更具体地涉及一种对S1P3受体具有拮抗作用的新型芳基酰胺脲衍生物及其作为活性成分的药物。本发明提供了下式（1）或其药学上可接受的盐所表示的芳基酰胺脲衍生物：其中R1表示可取代的C2-C8烷基，可取代的苯基，可取代的芳香杂环基，可取代的C2-C8烷氧基，或—NR4R5（其中R4和R5相同或不同，每个代表氢原子或可取代的低烷基，或R4和R5可以与相邻的氮原子连接形成可取代的含氮杂环环，其中R4和R5的情况下，它们相邻的氮原子可以连接形成可取代的含氮杂环环）；R2和R3相同或不同，每个代表氢原子，卤原子，卤代低烷基，低烷基，低炔基，低烷氧基，氰基，低烷酰基或低烷基磺酰基；A代表苯环或杂环环；D代表单键或亚甲基；m表示1到3的整数，n表示1到5的整数（但其中R1为乙氧基，R2为2,4-二氯基，R3为氢原子，A为苯环，D为亚甲基的情况和R1为乙氧基，R2为2,4-二氯基，R3为氢原子，2-甲基，4-甲基，4-甲氧基或4-乙氧基，A为苯环，D为单键的情况不包括在内）。
• Arylamidrazones as Novel Corticotropin Releasing Factor Receptor Antagonists
  作者：Dean M. Wilson、Andreas P. Termin、Long Mao、Michele M. Ramirez-Weinhouse、Valentina Molteni、Peter D. J. Grootenhuis、Keith Miller、Susan Keim、Gwendolyn Wise

  DOI：10.1021/jm025512y

  日期：2002.5.1

  The arylamidrazones have been found to be potent corticotropin releasing factor (CRF) receptor antagonists structurally distinct from previously reported CRF1 antagonists. Attempts to modify the arylamidrazone core suggested an important role for the anilino NH moiety. The right-hand-side 2-nitro feature in lead 1 could be replaced with substituents methyl, chloro, cyano, or trifluoromethyl with a 4- to 10-fold reduction in receptor binding. With appropriate left-hand-side modifications, this potency loss could be recovered.
• Metal-Assisted Oxidative Cyclization of Arylamidrazones I. Synthesis of 3-Acetyl-1,4-dihydro-1-phenyl-1,2,4-benzotriazine
  作者：Mousa Z. Al-Noaimi、Raid J. Abdel-Jalil、Mustafa M. El-Abadelah、Salim F. Haddad、Younis N. H. Baqi、Wolfgang Voelter

  DOI：10.1007/s00706-006-0465-5

  日期：2006.6

  In the presence of RuCl3, N-phenylamidrazone underwent oxidative cyclization into 1,4-dihydro-i-phenyl-1,2,4-benzotriazine, the structure of which is established by spectral and X-ray diffraction data.
• FISERA L.; KOVAC J.; LESKO J.; SMAHOVSKY V., CHEM. ZVESTI, 1981, 35, NO 1, 93-104
  作者：FISERA L.、 KOVAC J.、 LESKO J.、 SMAHOVSKY V.

  DOI：——

  日期：——